<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">79148</article-id><article-id pub-id-type="doi">10.7554/eLife.79148</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Aminomethanesulfonic acid illuminates the boundary between full and partial agonists of the pentameric glycine receptor</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-276051"><name><surname>Ivica</surname><given-names>Josip</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-115789"><name><surname>Zhu</surname><given-names>Hongtao</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1522-0500</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276052"><name><surname>Lape</surname><given-names>Remigijus</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-5270"><name><surname>Gouaux</surname><given-names>Eric</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8549-2360</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-77816"><name><surname>Sivilotti</surname><given-names>Lucia G</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7943-604X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Neuroscience, Physiology and Pharmacology</institution>, <institution>University College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Vollum Institute</institution>, <institution>Oregon Health and Science University Hospital</institution>, <addr-line><named-content content-type="city">Portland</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-114412"><name><surname>Goldschen-Ohm</surname><given-names>Marcel P</given-names></name><role>Reviewing editor</role><aff><institution>University of Texas at Austin</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>gouauxe@ohsu.edu</email> (EG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>l.sivilotti@ucl.ac.uk</email> (LS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>08</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e79148</elocation-id><history><date date-type="received"><day>31</day><month>03</month><year>2022</year></date><date date-type="accepted"><day>16</day><month>08</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Ivica et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Ivica et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-79148-v1.pdf"/><abstract><p>To clarify the determinants of agonist efficacy in pentameric ligand-gated ion channels we examined a new compound, aminomethanesulfonic acid (AMS), a molecule intermediate in structure between glycine and taurine. Despite wide availability, to date there are no reports of AMS action on glycine receptors, perhaps because AMS is unstable at physiological pH. Here we show that at pH 5, AMS is an efficacious agonist, eliciting in zebrafish α1 glycine receptors a maximum single channel open probability of 0.85, much greater than that of β-alanine (0.54) or taurine (0.12), and second only to that of glycine itself (0.96). Thermodynamic cycle analysis of the efficacy of these closely related agonists shows supra-additive interaction between changes in the length of the agonist molecule and the size of the anionic moiety. Single particle cryo-EM structures of AMS-bound glycine receptors show that the AMS-bound agonist pocket is as compact as with glycine, and three-dimensional classification demonstrates that the channel populates the open and the desensitized states, like glycine, but not the closed intermediate state associated with the weaker partial agonists, β-alanine and taurine. Because AMS is on the cusp between full and partial agonists, it provides a new tool to help us understand agonist action in the pentameric superfamily of ligand-gated ion channels.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>Project grant MR/R009074/1</award-id><principal-award-recipient><name><surname>Sivilotti</surname><given-names>Lucia G</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 GM100400</award-id><principal-award-recipient><name><surname>Gouaux</surname><given-names>Eric</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The coordinates and volumes for the cryo-EM data have been deposited in the Electron Microscopy Data Bank under accession codes EMD-26316, EMD-26315, and EMD-26317. The coordinates have been deposited in the Protein Data Bank under accession codes 7U2N, 7U2M. and 7U2O.All data generated during this study is included in the manuscript and supporting files, Source data spreadsheets are provided for the electrophysiology data.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Zhu H</collab><collab>Gouaux E</collab></person-group><year iso-8601-date="2022">2022</year><source>A novel compound mimics the structural and functional effects of the full agonist glycine on glycine channels-desenstized state</source><ext-link ext-link-type="uri" xlink:href="https://www.emdataresource.org/EMD-26315">https://www.emdataresource.org/EMD-26315</ext-link><comment>EMD-26315</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Zhu H</collab><collab>Gouaux E</collab></person-group><year iso-8601-date="2022">2022</year><source>A novel compound mimics the structural and functional effects of the full agonist glycine on glycine channels-open state</source><ext-link ext-link-type="uri" xlink:href="https://www.emdataresource.org/EMD-26316">https://www.emdataresource.org/EMD-26316</ext-link><comment>EMD-26316</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Zhu H</collab><collab>Gouaux E</collab></person-group><year iso-8601-date="2022">2022</year><source>A novel compound mimics the structural and functional effects of the full agonist glycine on glycine channels-expanded open state</source><ext-link ext-link-type="uri" xlink:href="https://www.emdataresource.org/EMD-26317">https://www.emdataresource.org/EMD-26317</ext-link><comment>EMD-26317</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Zhu H</collab><collab>Gouaux E</collab></person-group><year iso-8601-date="2022">2022</year><source>A novel compound mimics the structural and functional effects of the full agonist glycine on glycine channels-desenstized state</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7u2m">https://www.rcsb.org/structure/7u2m</ext-link><comment>PDB, 7U2M</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Zhu H</collab><collab>Gouaux E</collab></person-group><year iso-8601-date="2022">2022</year><source>A novel compound mimics the structural and functional effects of the full agonist glycine on glycine channels-open state</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7u2n">https://www.rcsb.org/structure/7u2n</ext-link><comment>PDB, 7U2N</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Zhu H</collab><collab>Gouaux E</collab></person-group><year iso-8601-date="2022">2022</year><source>A novel compound mimics the structural and functional effects of the full agonist glycine on glycine channels-expanded open state</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7u2o">https://www.rcsb.org/structure/7u2o</ext-link><comment>PDB, 7U2O</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-79148-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>